Rodrigo Ruiz-Soto

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine

Lainie P. Martin, Jason Konner, Kathleen N. Moore et al. · Gynecologic Oncology · 2017 · 139 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245409 (XL765), a Novel, Orally Administered PI3K/mTOR Inhibitor in Patients with Advanced Solid Tumors

Kyriakos P. Papadopoulos, Josep Tabernero, Ben Markman et al. · Clinical Cancer Research · 2014 · 95 citations · Full text

Medicine, Oncology, Pharmacology +16

Cytokine gene expression in cirrhotic and non-cirrhotic human liver

Luis Llorente, Yvonne Richaud‐Patín, Natasha Alcocer‐Castillejos et al. · Journal of Hepatology · 1996 · 64 citations

Life Sciences, Immunology, Molecular Biology +14

Phase I Safety and Pharmacokinetic Study of the PI3K/mTOR Inhibitor SAR245409 (XL765) in Combination with Erlotinib in Patients with Advanced Solid Tumors

Pasi A. Jänne, Roger B. Cohen, Alexander Laird et al. · Journal of Thoracic Oncology · 2014 · 49 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

An Open-Label, Multicenter, Randomized, Phase II Study of Pazopanib in Combination with Pemetrexed in First-Line Treatment of Patients with Advanced-Stage Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Enriqueta Felip, Benjamin Besse et al. · Journal of Thoracic Oncology · 2013 · 37 citations · Full text

Medicine, Oncology, Pharmacology +12